Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Clinigence Holdings, Inc. | clnh123120form10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Clinigence Holdings, Inc. | ex32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Clinigence Holdings, Inc. | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - Clinigence Holdings, Inc. | ex31_1.htm |
| EX-3.1X - EXHIBIT 3.1X - Clinigence Holdings, Inc. | ex3_1x.htm |
| EX-3.1VIII - EXHIBIT 3.1VIII - Clinigence Holdings, Inc. | ex3_1viii.htm |
| EX-3.1X - EXHIBIT 3.1X - Clinigence Holdings, Inc. | ex3_1ix.htm |
Exhibit 32.2
CERTIFICATION
PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying Annual Report of Clinigence Holdings, Inc. (the “Company”) on Form 10-K for the twelve months ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Bowen, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fully presents, in all material respects, the financial condition and results of operations of the Company.
| March 31, 2021 | By: /s/ Michael Bowen | |
| Michael Bowen | ||
| Principal Financial Officer |